SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Maul Coin

Maul Coin is generating buzz among traders who are attracted to its active developer engagement and the community's push to build organic momentum, despite the project's early stage and lack of an official chart. Investors are actively discussing the potential for a significant breakout, emphasizing the need for sustained volume and broader social media promotion to move the token toward mainstream visibility.

The Mullen Army Token originated from a dedicated community of retail investors who faced challenges in the traditional stock market. We united to create a cryptocurrency that embodies our principles and aspirations for a fair financial system.     We provide a platform for retail investors to engage in a transparent and fair financial market. Our efforts include grassroots marketing, community engagement, and educational content to empower our investors.

MullenArmy

MullenArmy (MULN CRYPTO) is currently trending as members debate its viability, with many in the community labeling it a pump-and-dump scheme or comparing it to the Mullen Automotive stock decline. While some users attempt to rally interest through community-led narratives and crypto-market speculation, others are actively warning investors to exit to avoid potential financial losses.

iShares Inc. - iShares MSCI Mexico ETF

iShares MSCI Mexico ETF

Investors are actively debating the long-term viability of Mexico as a manufacturing hub, with some noting its strategic importance in nearshoring supply chains while others warn of socio-economic decay and political risks. The community is focused on the impact of trade tariffs and US-Mexico relations on the performance of $EWW.

XRP is a decentralized digital asset and the native token of the XRP Ledger, a Layer 1 blockchain designed for high-performance global payments. Its primary value proposition is offering a fast, cost-effective alternative to traditional banking systems by enabling near-instant cross-border settlements that finalize in three to five seconds. By serving as a neutral bridge asset between different fiat currencies, it helps financial institutions lower liquidity costs and eliminates the need for pre-funded accounts.  The network is unique because it utilizes a federated consensus protocol instead of energy-intensive mining or staking. This system achieves deterministic finality through a Unique Node List of trusted validators who must reach an eighty percent agreement threshold to permanently record transactions. This infrastructure supports a sustained throughput of 1,500 transactions per second and includes a built-in decentralized exchange that allows for the automated trading of any tokenized asset without intermediaries.  The project traces its origins back to 2004 with Ryan Fugger before being co-founded in its modern form by Jed McCaleb and Chris Larsen. The company, now known as Ripple, works with major financial institutions as partners and investors to build global payment solutions. To protect the network from spam, a small amount of XRP is burned during every transaction, and the token is further utilized by institutions as collateral to access traditional markets and manage digital asset infrastructure.  Institutional adoption of the asset reached a major milestone in November 2025 when the SEC approved the first wave of spot XRP ETFs. These products, offered by major issuers including Bitwise, Grayscale, 21Shares, Canary Capital, and Franklin Templeton, are now listed on prominent exchanges like the NYSE Arca, Nasdaq, and Cboe BZX. While Ripple remains a key contributor to the ecosystem, the underlying XRP Ledger continues to operate as an open-source and decentralized network.

Ripple

The XRP community remains deeply divided, with some investors accumulating tokens in anticipation of regulatory clarity and institutional adoption, while others express frustration over long-term price stagnation and perceived lack of progress. Debates are currently fueled by speculation surrounding the Clarity Act and the expansion of Ripple's payment infrastructure, leading to a polarized environment between optimistic long-term holders and disillusioned skeptics.

REalloys, Inc. is engaged in the rebuilding of domestic supply chain resilience for rare earth elements and magnets. It is involved in recycling, mining, oxide production, metallization, alloying, and magnet manufacturing. The company was founded on October 4, 2011 and is headquartered in Boca Raton, FL.

REalloys Inc.

REalloys Inc. is trending as investors monitor its development as a rare earth metals processor amid increasing urgency for U.S.-aligned supply chains. The community is actively debating the stock's long-term potential in the defense sector, with heavy discussions focused on the company's advisory board appointments, defense-related contracts, and the risks versus rewards associated with future production timelines.

KalVista Pharmaceuticals, Inc. is a clinical stage pharmaceutical company, which engages in the discovery, development, and commercialization of small molecule protease inhibitors for diseases with significant unmet need. Its product candidates are inhibitors of plasma kallikrein being developed for two indications: Sebetralstat for HAE and Factor XIIa. The company was founded by T. Andrew Crockett, Edward P. Feener, and Lloyd Paul Aiello on March 26, 2004 and is headquartered in Framingham, MA.

KalVista Pharmaceuticals Inc

KalVista Pharmaceuticals is trending following an Endpoints News report alleging that FDA Commissioner Marty Makary attempted to force a rejection of the company's hereditary angioedema (HAE) drug application, an effort that was reportedly blocked by internal FDA scientists. Investors are actively discussing the stock's resilience, as the company maintains its path toward potential approval for the first oral on-demand treatment for HAE while bulls view the resulting price volatility as a favorable opportunity to increase positions.

Corvus Pharmaceuticals, Inc. engages in the development of immune modulator product candidates with the potential to treat solid cancers, T-cell lymphomas, autoimmune diseases, and infectious diseases. Its product pipeline includes B Cell Activator and Anti-CD73, Adenosine Production Inhibitor Anti-CD73, ITK Inhibitor, A2AR Inhibitor, Anti-CXCR2, and A2BR Inhibitor. The company was founded by Richard A. Miller, Peter A. Thompson, Joseph J. Buggy, and Erik Verner on January 27, 2014 and is headquartered in South San Francisco, CA.

Corvus Pharmaceuticals Inc

Corvus Pharmaceuticals is currently a focal point for investors due to clinical progress with its ITK inhibitor, soquelitinib, which has generated buzz for its potential to deliver durable, disease-modifying outcomes in atopic dermatitis and oncology. Community sentiment remains highly polarized, with intense debate between bulls anticipating a strategic buyout or short squeeze and skeptics emphasizing the inherent risks of a clinical-stage biotech and the potential for share dilution.

Invesco Exchange-Traded Fund Trust II - Invesco Solar ETF

Invesco Solar ETF

Invesco Solar ETF is navigating heightened market volatility as investors weigh the impact of shifting political landscapes and policy rhetoric on long-term renewable energy demand. The community is actively debating the sector's resilience, with many pointing to the structural necessity of solar to support the power-intensive growth of AI and data center infrastructure despite short-term regulatory headwinds.

ETF Series Solutions - ESS U.S.Global Jets ETF

US Global Jets ETF

Airline stocks are facing renewed volatility as the sector grapples with potential operational disruptions, fuel cost pressures, and broader economic uncertainty. The community is actively debating the sustainability of travel demand and debating whether the recent price action offers a contrarian value opportunity or a warning of deeper industry headwinds.

Investment Managers Series Trust II - Tradr 1.5X Short NVDA Daily ETF

Tradr 1.5X Short NVDA Daily ETF

The $NVDS ETF is seeing intense activity as traders debate whether Nvidias rally is sustainable or if a major pullback is imminent. The community is heavily focused on using this inverse instrument as a tactical hedge or aggressive short, with active discussions weighing technical support levels and the risks of betting against such a volatile market leader.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

LG Electronics, Siemens & more: Top stocks to buy today - Check list

Analysts are weighing in on several Indian companies. Kotak Securities sees potential in LG Electronics, while Bernstein is cautious on SBI Cards. Nuvama is bullish on Yatharth Hospitals' expansion plans. Goldman Sachs maintains a neutral stance on Nestle India, anticipating sustained growth. Citigroup views Siemens' business sale as having minimal impact.

State Bank of India, Amundi to jointly sell 10% stake in SBI Funds Management via IPO

BENGALURU/MUMBAI: State Bank of India the country’s largest lender by assets, and Europe’s biggest fund manager Amundi will jointly sell a 10% stake in SBI Funds Management through an initial public offering, the former said in a statement on Thursday. The asset management firm is India’s largest fund manager, collaring a market share of more than 15% and managing assets worth 120 billion rupees ($1.37 billion). The fund, a joint venture between SBI and Amundi, serves retail and institutional investors through mutual funds and investment portfolios. This is a second attempt by the partners to list the asset manager after an earlier announcement in 2021. This listing will unlock value for the asset manager, and the Indian market presents significant development potential, said Valérie Baudson, CEO of the French firm, which manages 2,317 billion euros in assets. This year is expected to be a record for India’s IPO market, with the proceeds surpassing the previous year’s $20.5 billion as some of the country’s largest firms - Tata Capital Electronics India and HDB Financial - offered blockbuster listings.

India’s SBI Card misses quarterly profit view on higher operating costs

India’s SBI Cards and Payment Services reported second-quarter profit below expectations on Friday, hurt by higher operating costs even as its asset quality improved. The company’s profit after tax rose 10% to 4.45 billion rupees for the three months ended September 30, but fell short of analysts’ average expectations of 5.79 billion rupees, according to data compiled by LSEG. Operating costs rose 24% from the year-ago quarter as the company increased spending on customer campaigns and offers, and paid out higher incentives to its corporate partners, the credit card firm said. Finance cost and provisions were largely stable year-on-year. SBI Card - majority-owned by the country’s largest lender by assets, State Bank of India - has struggled with asset quality stress and higher delinquencies on credit cards. The company had tightened underwriting over the last few quarters, which helped it improve asset quality. Its gross non-performing assets ratio improved to 2.85% from 3.07% in the previous quarter and 3.27% in the year-ago quarter.

Muhurat Trading 2025: Top stocks to buy in Samvat 2082 for up to 30% returns; check list

As India celebrates Samvat 2082, LKP Securities unveils its top stock picks for Muhurat Trading, anticipating up to 30% gains. The brokerage highlights Bajaj Finance, Divi's Laboratories, FSN E-Commerce Ventures, Swiggy, State Bank of India, and SBI Cards, citing strong technical indicators and bullish chart patterns for these selections.

Indian equity markets fell sharply on Tuesday, dragged by steep losses in the real estate, pharmaceutical, metals, and banking sectors. The Nifty closed well below a crucial support level at 24,890.The broader markets are likely to open lower on Thursday, with the Gift Nifty, an early indicator for the Nifty 50 index, down 0.35% at 24,660 at 8:25 am IST.Market participants will keep a close watch on key export sectors, including textiles, jewellery, and chemicals, as Donald Trump-imposed 50% tariffs on Indian goods came into effect on Wednesday.Investors will also monitor developments in India’s relations with China and Russia ahead of the Shanghai Cooperation Organisation (SCO) summit later this month.July’s industrial and manufacturing production data is scheduled for release after market hours.Stock WatchInterGlobe Aviation: The Rakesh Gangwal family is set to sell up to a 3.1% stake in IndiGo through block deals worth ₹7,027 crore, with a floor price of ₹5,808 per share, as reported by CNBC-TV18.SMS Pharmaceuticals: SMS Pharma received a US FDA Establishment Inspection Report with a “No Action Indicated” status for its Hyderabad Central Lab following an inspection from June 23 to 25, which concluded with zero Form 483 observations.Dr Reddy’s Laboratories: The Telangana High Court granted an interim stay on income tax reassessment proceedings related to the merger of Dr Reddy’s Holding with the company until the next hearing.BSE: Subsidiaries BSE Investments and BSE Administration and Supervision have secured board approvals to merge with BSE Technologies.United Breweries: United Breweries will invest ₹90 crore to set up a new canning line at Nizam Brewery, Telangana, adding 0.4 mhl capacity for premium Kingfisher and Heineken products, with all approvals in place.SBI Cards and Payment Services: SBI Cards partnered with Flipkart to launch a co-branded credit card aimed at enhancing affordability across Flipkart, Myntra, Shopsy, and Cleartrip.E2E Networks: E2E won an ₹88.02 crore order from IndiaAI for the immediate supply of 1,024 H200 SXM GPUs to GAN AI, which is tasked with building India’s foundational AI model.Newgen Software Technologies: Newgen bagged a ₹73.12 crore order for a customer’s scanning and digitization project.Oil India &amp; BPCL: Oil India and BPCL formed a joint venture to develop a city gas distribution network in Arunachal Pradesh, including CNG stations and PNG supply.Power Grid Corporation: Power Grid won the bid to establish an interstate transmission system in Karnataka to integrate renewable energy at Davanagere under the BOOT model.Lemon Tree Hotels: Lemon Tree signed a license agreement for a new resort in Pench, Maharashtra, to be managed by its subsidiary Carnation Hotels.HFCL: Subsidiary HTL secured a ₹101.82 crore contract from the Indian Army to supply tactical optical fiber cables and accessories.Himadri Speciality Chemical: Himadri earned ISCC PLUS certification, reinforcing its global standing in sustainable and traceable supply chains.Rail Vikas Nigam: RVNL signed a joint venture with Texmaco Rail &amp; Engineering to execute projects in railway and allied infrastructure, with 51:49 shareholding.Dr. Agarwal’s Group: The boards of Dr. Agarwal's Health Care and Dr. Agarwal's Eye Hospital have approved a merger scheme to unify operations and improve efficiency.Earnings TodayAJC Jewel Manufacturers and Prabhat Technologies (India)Mainboard ListingMangal Electrical&nbsp;Active IPOsVikran Engineering and Anlon HealthcareFor updates and corrections, email newsroom[at]stocktwits[dot]com.

The digital broadcast on the facade of the Bombay Stock Exchange (BSE) displays the benchmark share index SENSEX crossing 32,000 points, on July 13, 2017 in Mumbai, India. (Photo by Kunal Patil/Hindustan Times via Getty Images)

Trading Radar For August 28: Dr Reddy’s, United Breweries, Power Grid Corp, IndiGo Stocks Are On Investors’ Watchlist

All eyes are on key export sectors, including textiles, jewelry, and chemicals, as the 50% tariffs on Indian goods came into effect on Wednesday.

Equity

Indian shares dragged down by Kotak Mahindra Bank, TCS; trade deal delay weighs

Indian shares fell on Monday as financials and IT declined due to weak results from Kotak Mahindra Bank and Tata Consultancy Services’ layoff plans, respectively, and as uncertainty over trade talks with the U.S. hit overall sentiment. The Nifty 50 fell 0.63% to 24,680.9 points, and the BSE Sensex lost 0.7% to 80,891.02. The broader small-caps and mid-caps lost 1.3% and 0.8%, respectively. Negotiations between India and the United States remained deadlocked over tariff cuts on agriculture and dairy products, dimming hopes of an interim deal ahead of U.S. President Donald Trump’s August 1 deadline. However, a framework trade agreement between the U.S. and European Union eased fears of a bigger trade war between the two allies, which account for almost a third of global trade. Thirteen of the 16 major sectors logged losses. High-weightage financials and private banks lost 0.7% and 1.7%, respectively, dragged by a 7.4% fall in Kotak Mahindra Bank after it posted a drop in quarterly profit.

SBI Cards & Payment Services Ltd. engages in the business of issuing credit cards to consumers in India. It provides a co-brand credit card for doctors which offers medical professional liability insurance to cardholders. The company was founded in 1998 and is headquartered in Gurgaon, India.

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	6.79	--	--	N/A
Q3 '25	6.26	5.85	-6.62%	MISSED
Q2 '25	6.03	4.67	-22.49%	MISSED
Q1 '25	6.23	5.84	-6.26%	MISSED
Q4 '24	4.96	--	--	N/A

SBICARD.NSE
SBI Cards & Payment Services Limited

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest SBICARD.NSE News

SBICARD.NSESBI Cards & Payment Services Limited